Stratifin Promotes Hepatocellular Carcinoma Progression by Modulating the Wnt/β-Catenin Pathway

Table 2

Univariate and multivariate survival analyses of OS in HCC patients from online databases.

Variables	Univariate analysis		value	Multivariate analysis		value
	HR	95% CI		HR	95% CI
Age	1.006	0.987–1.025	0.538	1.012	0.991–1.033	0.275
Gender	0.845	0.516–1.385	0.505	1.022	0.585–1.787	0.938
Grade	0.996	0.726–1.366	0.979	1.159	0.821–1.636	0.403
AJCC TNM	1.921	1.485–2.485	0.001	2.041	0.642–6.488	0.227
T (tumor)	1.844	1.451–2.344	0.001	0.937	0.320–2.745	0.906
N (node)	2.018	0.492–8.279	0.330	1.080	0.125–9.310	0.944
M (metastasis)	3.867	1.208–12.374	0.023	0.755	0.191–2.987	0.689
SFN expression	1.009	1.005–1.013	0.001	1.008	1.004–1.013	0.001

CI: confidence interval; HCC: hepatocellular carcinoma; HR: hazard ratio; OS: overall survival; SFN: stratifin.